Immune deficiency in glycogen storage disease type 1B
- PMID: 9007171
Immune deficiency in glycogen storage disease type 1B
Abstract
Patients with glycogen storage disease type 1B present the clinical features of glycogen storage disease type 1A. In addition, they are susceptible to recurrent bacterial infection and have recurrent oral ulcers and occasionally Crohn's-like disease. There features are due to immune dysfunction caused by a combination of neutropenia and impaired phagocytic functions.
Similar articles
-
[Glycogenoses type 1b and 1c].Pediatrie. 1988;43(8):661-5. Pediatrie. 1988. PMID: 3065719 Review. French.
-
[Cutaneous ulcers and glycogen storage disease type 1b].Ann Dermatol Venereol. 2010 May;137(5):377-80. doi: 10.1016/j.annder.2010.03.017. Epub 2010 Apr 28. Ann Dermatol Venereol. 2010. PMID: 20470920 French.
-
[Glycogen storage disease type Ib].Ryoikibetsu Shokogun Shirizu. 2000;(32):349-52. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11212741 Review. Japanese. No abstract available.
-
Inflammatory bowel disease-like colitis in a young Turkish child with glycogen storage disease type 1b and elevated platelet count.Turk J Pediatr. 2005 Apr-Jun;47(2):180-2. Turk J Pediatr. 2005. PMID: 16052862
-
Inflammatory bowel disease in glycogen storage disease type 1 B.Pediatr Radiol. 1995 Nov;25 Suppl 1:S160-2. Pediatr Radiol. 1995. PMID: 8577513
Cited by
-
The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression.Cancer Cell Int. 2006 Mar 27;6:7. doi: 10.1186/1475-2867-6-7. Cancer Cell Int. 2006. PMID: 16566826 Free PMC article.
-
Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.Gene Ther. 2007 Feb;14(3):219-26. doi: 10.1038/sj.gt.3302869. Epub 2006 Sep 28. Gene Ther. 2007. PMID: 17006547 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources